Krystal Biotech, Inc. (KRYS) Net margin 2023–2025
Krystal Biotech, Inc. (KRYS) net profit margin by fiscal year — reported net income divided by reported revenue.
52.6%FY2025 · since FY2023: 21.6% → 52.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 52.6% | +21.9 pp |
| FY2024 | 30.7% | +9.1 pp |
| FY2023 | 21.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More KRYS financial trends
KRYS RevenueKRYS Net incomeKRYS Gross profitKRYS Gross marginKRYS Operating incomeKRYS Operating marginKRYS Operating cash flowKRYS Free cash flowKRYS Capital expendituresKRYS Return on equityKRYS Stock buybacksKRYS Dividends paidKRYS Total assetsKRYS Total liabilitiesKRYS Shareholders’ equityKRYS overview →